Table 1.
Experimental HS severity questionnaire.
Fig 1.
HS Epidemiology study flow chart.
Table 2.
Demographics, duration of the disease and DLQI scores by Hurley Stage of HS patients enrolled in the HS severity questionnaire validation study.
Table 3.
Combined past and current treatments for HS by Hurley Stage in patients enrolled in the HS severity questionnaire validation study.
Table 4.
Impact of HS on quality of life in patients enrolled in the HS severity questionnaire validation study.
Table 5.
Association between individual questions from the HS severity questionnaire and Hurley Stage of moderate versus mild, and severe versus mild.
Table 6.
Predictive ability, sensitivity and specificity of the experimental self-administered HS severity questionnaire and DLQI against the Hurley Stage.
Table 7.
Profilea of Non-participantsa versus participants.
Table 8.
Suspected HS cases by state and national total.
Table 9.
Estimated prevalence of HS in Australia overall and by gender.
Table 10.
Location of boils in suspected HS individuals, total and by gender.
Table 11.
Characteristics of people living with HS in Australia compared to non-HS.
Table 12.
Characteristics of the 7 confirmed cases of HS through physical examination among the 12 who attended the visit at the dermatologist.
Table 13.
Agreement between clinical and expert assessments in suspected HS individuals attending the dermatology visit (N = 12).